Binex Co. Ltd. | Cash Flow

Fiscal year is January-December. All values KRW Millions.
2013
2014
2015
2016
2017
Net Income before Extraordinaries
3,538
10,360
6,813
2,942
11,519
Depreciation, Depletion & Amortization
5,948
6,203
6,339
8,090
8,983
Other Funds
993
23
190
1,483
367
Funds from Operations
2,690
10,366
8,162
8,043
2,291
Changes in Working Capital
408
10,034
12,659
4,245
5,845
Net Operating Cash Flow
2,282
332
4,497
3,799
8,136
Capital Expenditures
2,733
2,859
65,085
5,339
2,789
Sale of Fixed Assets & Businesses
341
2
8
1,532
7
Purchase/Sale of Investments
14,026
12,891
2,952
8,448
517
Net Investing Cash Flow
11,698
13,077
61,968
12,255
4,336
Issuance/Reduction of Debt, Net
27,460
4,736
16,575
2,350
1,380
Net Financing Cash Flow
17,563
88
54,713
2,766
1,067
Net Change in Cash
8,137
13,330
11,716
5,643
4,823
Free Cash Flow
4,383
2,174
69,006
1,286
5,868
Net Assets from Acquisitions
-
-
-
-
2,071
Other Sources
1,113
4,918
157
-
-
Change in Capital Stock
10,890
4,624
38,327
1,067
54
Exchange Rate Effect
10
10
36
47
44
Other Uses
1,049
1,874
-
-
-

About Binex Co.

View Profile
Address
368-3 Dadae-ro
Busan BU 49469
Korea, Republic Of
Employees -
Website http://www.bi-nex.com
Updated 09/14/2018
BINEX Co., Ltd. engages in the manufacture and sale of pharmaceuticals. It operates through the following business divisions: Bio, Pharmaceutical Manufacruing and Sales, and others. The bio division provides bio pharmaceutical consignment production and bio analysis services.